Welcome to Beyond Psychedelics where we explore the art, science, and business behind the world’s fastest-growing industry. You’ll hear from experts around the world on how psychedelics and innovative healing therapies are creating massive breakthroughs and an entirely new &amp; emerging business sector.Ketamine, Psilocybin, MDMA, and TMS aren’t just coming--they’re already here. This is Beyond Psychedelics!

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/10/10/18/5d777b60-6dcc-4088-9d26-c413c8e0489d_beyond-alex_camargo_.mp3

Today, we have the privilege of speaking with Dr. Alex Camargo, a psychologist and the director of the Psychedelic Harm Reduction Integration Program at Fluence. Dr. Camargo is at the forefront of the psychedelic space, providing harm reduction and integration support to clients seeking healing and growth through psychedelic experiences. In this thought-provoking conversation, Dr. Camargo shares his personal journey into the world of psychedelic therapy and the profound impact it has had on his clients. He emphasizes the importance of integration, the power of the therapeutic relationship, and the potential of psychedelics to revolutionize mental health care. Let&#39;s take a deep dive into these themes and explore their implications for the future of psychedelic therapy.

Psychedelic Therapist Dr. Alex Camargo Discusses the Power of Integration

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/10/2/14/44bc8d08-6ce1-4703-b9cc-0e4d388cf263_beyond-nick_palego_beyond_marketing.mp3

Nick Polega shares his personal journey and experiences with psychedelic medicine, specifically psilocybin. He started using psilocybin recreationally in college but soon realized that there was more to it than just a recreational drug. He delved deeper into the therapeutic potential of psychedelics and found that they brought a new level of awareness and understanding to his life. Nick now works with psychedelic clinics across the country and helps them improve their processes and systems. Nick&#39;s journey with psychedelics began at the age of 20 when he read &#34;The Psychedelic Experience&#34; by Timothy Leary. Intrigued by the ancient use of psychedelic substances for healing and transformation, Nick started exploring psilocybin, commonly known as magic mushrooms. However, his initial recreational use did not align with his expectations of transformation. It was only when he approached psychedelics with intention and a deeper understanding that he began to experience their true power. One of the most profound impacts of psychedelic medicine is the heightened level of self-awareness it brings. Through his own experiences, Nick discovered that psychedelics allowed him to connect with his subconscious and gain a deeper understanding of himself and the world around him. This newfound awareness enabled him to identify his triggers, understand the nuances of life, and approach challenges with a more centered mindset.

Exploring Personal Journeys and the Impact of Psychedelic Medicine

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/9/22/13/72dda070-b6c8-4970-aada-1d2b63c0e5cf_beyond-_charles_patti.mp3

In today&#39;s episode, we have two incredible guests who are making waves in the psychedelic space. Charles Patti, the founder of Myself Wellness, a boutique ketamine clinic, and Scott Theaman, the CEO of Beyond Marketing, a leading growth partner in the industry. Together, they share their personal stories of healing and discuss the future of psychedelic medicine. Charles Patti, founder of Myself Wellness, and Scott Theaman, CEO of Beyond Marketing, discuss their experiences with psychedelics and the healing potential of these substances. Charles shares his personal journey of overcoming addiction and finding healing through psychedelic experiences. They discuss the benefits of ketamine therapy and the potential of MDMA in treating mental health issues. They also talk about the importance of accessibility to these treatments and the work being done by the Warriors of Consciousness nonprofit organization. Inspired by his own healing journey, Charles Patti founded Myself Wellness, a ketamine clinic in Bonita Springs, Florida. The clinic offers psychedelic ketamine therapy, which Charles believes is a powerful tool for mental health and personal transformation. He explains why he chose the intramuscular (IM) route for ketamine administration and how it differs from other methods. Charles describes ketamine as the &#34;Trojan horse&#34; of the psychedelic renaissance. Unlike other compounds like psilocybin or MDMA, ketamine is an FDA-approved dissociative anesthetic, making it more accessible and acceptable to a wider audience. Charles believes that ketamine therapy can pave the way for the acceptance and integration of other psychedelic medicines in the future.

Charles Patti And Scott Theaman Discuss The Power of Psychedelic Therapy

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/9/5/18/53f198e1-0d6b-46d2-aae3-e2b156d86822_beyond-_kimberly_juroviesky.mp3

Kimberly Juroviesky shares her journey from being an Air Force nurse midwife to developing complex regional pain syndrome and her mission to make ketamine treatment more accessible. She discusses the challenges of insurance coverage for ketamine and the efforts of the Ketamine Task Force to advocate for coverage. Kimberly also talks about the task force&#39;s application to Medicare and their plans for a large research study to address gaps in current ketamine research. Kimberly Juroviesky is a retired practitioner and nurse midwife with an impressive background in healthcare. She attended Columbia University and the University of Medicine and Dentistry in New Jersey. After serving in the US Air Force, she developed complex regional pain syndrome, which led to a shift in her career. Kimberly is now dedicated to helping others access ketamine treatment and is a member of the Ketamine Task Force.

Ketamine Task Force Fights for Accessibility of Ketamine Treatment

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/9/12/13/159f0dea-f9ec-4607-96aa-220679b7611f_beyond-gv_freeman.mp3

In this episode of the Beyond Psychedelic podcast, host A interviews GV Freeman, a transformational guide with extensive experience in the field. They discuss GV&#39;s background and journey that led him to become a transformational guide, as well as the concept of a transformational guide itself. GV shares his personal experiences with substances and how they have shaped his path. He also talks about the importance of balancing the sacred and the secular in his work and the challenges of finding a middle ground. The conversation touches on the cost of psychedelic-assisted psychotherapy and the need for professionalism and safety in the field. GV emphasizes the importance of investing in one&#39;s own personal growth and the challenges of navigating the intersection between spirituality and recovery. The episode concludes with a discussion on the direction of the psychedelic movement and the role of researchers and scientists in shaping its future. GV Freeman is a transformational guide with over 20 years of experience in the field. He helps individuals unstuck themselves and offers an integrated approach to coaching, consulting, and sacred medicine. GV has a diverse background, having worked in corporate for 25 years before transitioning to his current role. He has also been in recovery for almost 16 years and offers psychedelic substances to individuals, which has led to some controversy within the recovery community.

Transformational guide discusses psychedelics and the future of mental health

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/9/5/18/64ecbd27-2a92-4153-a794-ea82e34dc0e1_beyond-daphne_barron.mp3

Daphne Barron, founder of Serotina Media, joins the conversation to discuss the importance of building a strong brand in the psychedelic space. She emphasizes the need for businesses to clearly communicate their values and differentiate themselves from competitors. Daphne explains that branding is the hardest part of marketing and requires a deep understanding of the target audience. She also highlights the role of social media in brand building and emphasizes the importance of authenticity and personalization. Daphne advises businesses to focus on platforms that align with their capabilities and to create sustainable content strategies. Daphne Barron is the founder of Serotina Media, a media agency that specializes in social media marketing for disruptor brands. With a background in science and a passion for creativity, Daphne helps businesses communicate their unique value and connect with their target audience. She has been running Serotina Media for five years and has a team of twelve employees. Daphne is based in Toronto, Canada.

The Importance of Building a Strong Brand in the Psychedelic Space

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/9/8/13/5bd32ce6-c9cb-42ac-86f7-d652d6963a64_beyond-tyler_rauert.mp3

Tyler Rauert, a senior counsel for Fortis Law Partners LLC corporate team in Colorado, shares his journey and expertise in various fields, including law, national security, and international business transactions. He discusses the evolution of the psychedelic medicine space in Colorado and the importance of balancing progress with caution. Tyler highlights the potential of psychedelic-assisted therapies to make a significant impact on people&#39;s lives and explains his decision to make himself available for the psychedelic renaissance. He emphasizes the need to learn from past mistakes and approach the industry with care. Tyler Rauert is a senior counsel for Fortis Law Partners LLC corporate team in Colorado. He has a diverse background in various fields, including merger acquisitions, entity formation, international business transactions, SaaS software, data privacy, and intellectual property. Tyler has worked as the VP of Legal at PAX Eight, contributed to the global data privacy posture at a Berkshire Hathaway company, and served as the lead marketing and brand protection attorney for Chipotle Mexican Grill. He also has experience in national security and international law for the US Department of Defense.

Tyler Rauert discusses the evolving landscape of psychedelic medicine in Colorado

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/8/18/14/11812930-cb9a-48bd-8529-a8e6ebeab0bd_beyond-_diego_uvalde.mp3

Diego Ugalde is a Veteran with 15 years of experience as a Navy SEAL. His career began in San Diego, CA in 1992 as a Hospital Corpsman in the hopes of becoming a SEAL but his plans unexpectedly changed when he was dropped four months into BUD/S training. After eight years of repentance over being unsuccessful, he trained his way back into shape. Despite separating his shoulder mid-way through, he was able to continue on and graduate with his Class 246. Diego was ultimately promoted to the rank of Senior Chief Petty Officer, served three combat tours in Iraq, and participated in over 250 highly classified combat and Advanced Special Operations missions.  He is a gifted leader highly experienced in mentoring and training multifaceted and multicultural teams and organizations. Diego was awarded four Navy Commendation Medals (with Combat Valor), three Navy Achievement Medals, and one combat action ribbon.

Diego Ugalde, CEO of The Trident Approach on Transformation, Integration, and Leadership: Unveiling the Trident Approach

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/9/6/4/a7b7e0fd-e107-416b-be26-e5abf81158b3_d_psychedelic_journey_-_a_personal_perspective.mp3

In this episode, Dr. Karan and Sebastian have a candid conversation about Sebastian&#39;s personal journey with psychedelics, and how it is helped him with his own personal journey as a son, husband, and a man. This episode is about the personal perspective one has with psychedelic transformation.

Psychedelic Journey - A personal perspective

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/8/3/17/42636ef4-304e-4534-9330-ee75b1466fe6_and_trust_while_providing_clinical_treatments_.mp3

Building rapport and trust with patients is an essential aspect of providing clinical treatments. Patients are more likely to be receptive to interventions and adhere to treatment plans when they feel comfortable and supported by their healthcare providers. One of the best practices in this regard is active listening. Clinicians should attentively listen to patient&#39;s concerns, fears, and goals without interrupting, allowing them to express themselves fully. By demonstrating empathy and understanding, healthcare professionals can validate patients&#39; emotions and experiences, making them feel valued and respected.Another vital aspect is clear and transparent communication. Healthcare providers should explain treatment options, potential risks, and expected outcomes in a manner that patients can easily understand. Using layman&#39;s terms and avoiding jargon helps build trust by empowering patients to make informed decisions about their care. Furthermore, clinicians should always be honest about the limitations of treatments and the potential challenges patients might encounter, fostering an environment of open dialogue and trust.Demonstrating competence and expertise is crucial for establishing trust with patients. Clinical treatments should be evidence-based and up-to-date with the latest research and best practices. Healthcare providers should also be open to continuous learning and improvement to ensure that patients receive the best possible care.

Best Practices and Building Rapport and Trust While Providing Clinical Treatments

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/7/21/10/271a5ca3-a47b-4622-97ab-f798975298b7_beyond-jack_cavanaugh_part_2.mp3

Jumping back into Cognitive rehabilitation, which is a therapeutic approach designed to help individuals regain cognitive function and improve their daily functioning after experiencing brain injuries or cognitive decline. Today they dive more into how it utilizes various techniques and exercises to stimulate neural pathways, and enhance memory, attention, and problem-solving skills, ultimately promoting brain restoration and adaptation to achieve optimal cognitive performance.John Cavanagh is an accomplished executive in the field of neurology and brain health, known for his expertise in cognitive rehabilitation and brain restoration therapies. He currently serves as an executive at Restore Brain, PLLC, a prominent healthcare organization based in Dallas, Texas. With a passion for improving the lives of individuals affected by neurological conditions, John has played a pivotal role in developing innovative treatment protocols and expanding the reach of Restore Brain&#39;s services.

Cognitive Rehabilitation And Brain Restoration Therapies Part 2

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/7/14/13/8108260f-4f1c-4d8b-a30b-112b0102804e_beyond-psy_sci_2023_recap.mp3

The Psychedelic Science 2023 spanned one week with events on-site at the Colorado Convention Center and throughout Denver, CO from June 19-23. Classes and Workshops offered an opportunity to dive into the world of psychedelic medicine on Monday and Tuesday. Followed by the conference Tracks offer a curated guide of sessions focused on 11 exciting stages. Dr. Matthew W. Johnson, Ph.D., is a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world’s most published scientists on the human effects of psychedelics and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson earned his Ph.D. in experimental psychology at the University of Vermont in 2004.Working with psychedelics since 2004, Dr. Johnson published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. As Principle Investigator he developed and published the first research on psychedelic treatment of tobacco addiction in 2014. Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress in 2016. His 2018 psilocybin abuse liability review recommended placement in Schedule IV upon potential medical approval.

Psychedelic Science 2023 Recap And Dr. Matthew W. Johnson

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/7/7/10/fe9add72-78bf-46a2-9a56-5fa10f62e637_beyond-jack_cavanaugh_part_1.mp3

John Cavanagh is an accomplished executive in the field of neurology and brain health, known for his expertise in cognitive rehabilitation and brain restoration therapies. He currently serves as an executive at Restore Brain, PLLC, a prominent healthcare organization based in Dallas, Texas. With a passion for improving the lives of individuals affected by neurological conditions, John has played a pivotal role in developing innovative treatment protocols and expanding the reach of Restore Brain&#39;s services.In addition to his executive role at Restore Brain, John is also a visionary entrepreneur, having founded and established Manage Brain, LLC, a dynamic company based in Dallas, Texas. Manage Brain is dedicated to providing cutting-edge technologies and solutions for optimizing brain function, cognitive performance, and mental well-being. Under John&#39;s leadership, Manage Brain has emerged as a leading provider of neurofeedback systems and brain training programs that help individuals enhance their cognitive abilities and overcome neurological challenges.

Cognitive Rehabilitation And Brain Restoration Therapies Part 1

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/6/30/10/07aa623d-a493-44b5-9229-42ee0144d176_chedelic_assisted_therapies__tms_and_ketamine_.mp3

The future of neuromodulatory treatments &amp; psychedelic-assisted therapies holds immense promise in revolutionizing mental health treatment. Through rigorous research and growing acceptance, treatments like TMS, Ketamine, psilocybin, MDMA, and LSD are being recognized for their potential to alleviate conditions such as depression, anxiety, PTSD, and addiction. As clinical trials continue to demonstrate their safety and efficacy, we can anticipate a broader integration of these therapies into mainstream healthcare, accompanied by regulations to ensure responsible use and trained practitioners. With ongoing advancements and a shift in societal attitudes, psychedelic-assisted therapies have the potential to offer transformative healing experiences and pave the way for a new era of mental well-being.

Beyond Mental Health Treatments - The Future of Psychedelic and Neuromodulatory Medicine

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/6/23/19/5e663ffd-90ea-4308-8d9f-b2cf41274c21_racking_data_to_provide_better_medical_support.mp3

Tracking data can play a crucial role in enhancing the medical support provided during psychedelic treatments. By closely monitoring patients&#39; experiences, physiological responses, and mental well-being throughout the treatment process, healthcare professionals can gain valuable insights into the efficacy and safety of psychedelic therapies. Analyzing this data can help identify patterns, personalize treatment plans, and optimize dosage protocols, ultimately leading to more targeted and effective therapeutic outcomes. Additionally, tracking data enables the identification of potential adverse effects, allowing for timely interventions and adjustments to ensure patients receive the best possible care during their psychedelic-assisted therapy.

Tracking Data To Provide Better Medical Support

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2023/6/15/22/03b50018-c50a-44a5-b271-b363e1df0946_d-1-how_psychedelics_are_transforming_medicine.mp3

Beyond Psychedelics is a podcast that explores the therapeutic potential of psychedelics and neuromodulation. The FDA is conducting clinical trials to determine safe dosages for patients and ketamine and MDMA are being used to create a distorted sense of self, leading to a disassociation from the current state of mind to a different state of mind. However, at-home ketamine usage is not regulated or supervised, leading to adverse effects or bad trips. Ketamine-assisted psychotherapy, along with therapy, results in higher efficacy for patients.  Ketamine blocks NMDA receptors, involved in the transmission of pain signals and mood regulation, leading to an increase in the most abundant neurotransmitter in the brain, glutamate, and a dreamlike state that alters the perception of time and space. The podcast emphasizes the importance of ongoing support for patients after treatment, as well as the need to treat the root cause of mental health issues, not just the symptoms. Mental health professionals need to incorporate other elements of mental health treatment, including counseling and EMDR, along with psychedelic treatments.

How Psychedelics Are Transforming Medicine

Welcome to Beyond Psychedelics where we explore the art, science, and business behind the world’s fastest-growing industry. You’ll hear from experts around the world on how psychedelics and innovative healing therapies are creating massive breakthroughs and an entirely new & emerging business sector.

Ketamine, Psilocybin, MDMA, and TMS aren’t just coming--they’re already here. This is Beyond Psychedelics!